All male patients with mutations in the ABCD1 gene eventually develop adrenomyeloneuropathy, a slowly progressive myelopathy with a typical onset in the third or fourth decade of life (Singh, 1997). Here, ABCD1 is linked to adrenomyeloneuropathy.